Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2007-10-02
2010-11-16
Anderson, Rebecca L (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S217090, C514S326000, C540S603000, C546S211000, C548S365700
Reexamination Certificate
active
07834046
ABSTRACT:
This invention relates to thiophene compounds of formula (I) shown below:Each variable in formula (I) is defined in the specification. These compounds can be used to treat cannabinoid-receptor mediated disorders.
REFERENCES:
patent: 5624941 (1997-04-01), Barth et al.
patent: 6620804 (2003-09-01), Chang et al.
patent: 6958339 (2005-10-01), Kubota et al.
patent: 2001/0011090 (2001-08-01), Kubota et al.
patent: 2005/0261281 (2005-11-01), Lazzari et al.
patent: 2008/0021031 (2008-01-01), Shia et al.
patent: 1709889 (2005-12-01), None
patent: 1623741 (2006-02-01), None
patent: 2053787 (1990-02-01), None
patent: WO 2007002559 (2007-01-01), None
Morimoto et al., caplus an 1970:456092, (1970).
Clark et al., “Decreased Incidence of Prostate Cancer with Selenium Supplementation: Results of a Double-Blind Cancer Prevention Trial,”British Journal of Urology, 81:730-734 (1998).
Clark et al., “Effects of Selenium Supplementation for Cancer Prevention in Patients with Carcinoma of the Skin,” JAMA, 276:1957-1963 (1996).
Diwadkar-Navsariwala et al., “Selenoprotein Deficiency Accelerates Prostate Carcingenesis in a Transgenic Model,”PNAS, 103(21):8179-8184 (2006).
Database CAS Online on STN, Chem. Abst., Accession No. 2005:1242633, US 20050261281 A1 (Lazzari et al.) Nov. 24, 2005.
Finar, “Preparation and Properties of Some Bipyrazolyls,” Journal of the Chemical Society, pp. 12288, (1956).
Tseng et al., “Bioisosteric Replacement of the Pyrazile 5-Aryl Moiety of N-(Piperidin-1-yl)-5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl-1H-pyrazole-3-caroxamide (SR141716A). A Novel Series of Alkynylthiophenes as Potent and Selective Cannabinoid-1 Receptor Antagonists,” J. Med. Chem., 51:5397-5412 (2008).
Obata et al., caplus an 1994:700884.
Chao Yu-Sheng
Hung Ming-shiu
Liao Jyh-hsiung
Shia Kak-shan
Tai Chia-Liang
Anderson Rebecca L
Coughlin Matthew P
National Health Research Institutes
Occhiuti Rohlicek & Tsao LLP
LandOfFree
Thiophene compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Thiophene compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Thiophene compounds will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4232897